David Bonita
General Partner · OrbiMed
David Bonita, a General Partner at OrbiMed, invests primarily in **biotech**, **digital health**, and **artificial intelligence** at the **Series A** and **Series B+** stages, with check sizes ranging from **
million to $75 million** [1][2]. His notable portfolio includes companies such as **Rampart Bioscience**, **Congruence Therapeutics**, **Repare Therapeutics**, and **Third Harmonic Bio**,…
- Stages: Pre-Seed, Seed, Series A
- Focus: Healthcare
- Location: New York, New York, United States
LinkedIn
Browse all investors · Browse founders
